(NDAQ) Nasdaq - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6311031081
Stock:
Total Rating 51
Risk 85
Buy Signal 0.65
| Risk 5d forecast | |
|---|---|
| Volatility | 27.8% |
| Relative Tail Risk | -1.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.23 |
| Alpha | -7.94 |
| Character TTM | |
|---|---|
| Beta | 0.765 |
| Beta Downside | 0.723 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.76% |
| CAGR/Max DD | 0.76 |
EPS (Earnings per Share)
Revenue
Description: NDAQ Nasdaq
Nasdaq, Inc. operates as a technology company that serves capital markets and other industries in the United States and internationally. It operates through three segments: Capital Access Platforms, Financial Technology, and Market Services. The company distributes historical and real-time market data; develops and licenses Nasdaq-branded indices and financial products; provides investor relations intelligence, governance solutions, and sustainability solution products for public and private companies, and organizations, as well as insights and workflow solutions; and operates listing platforms. It also offers Verafin, a cloud-based platform to detect, investigate, and report money laundering and financial frauds; AxiomSL, a risk data management and regulatory reporting solution; cloud-enabled and on-premises surveillance solutions to assist in complying with market rules, regulations, and internal market surveillance policies; Calypso, a platform providing cross-asset, front-to-back trading, treasury, risk, and collateral management solutions; and trade management and colocation services, as well as handles assets comprising cash equities, equity derivatives, currencies, various interest-bearing securities, commodities, energy products, and digital currencies. In addition, the company provides equity derivative trading and clearing, cash equity trading and fixed income, currency and commodities trading, and fixed income trading and clearing services, as well as tape plan data services; operates various exchanges, including derivatives, commodities, cash equity, debt, structured products, and exchange traded products; and offers clearing, settlement, and central depository services. The company was formerly known as The NASDAQ OMX Group, Inc. and changed its name to Nasdaq, Inc. in September 2015. Nasdaq, Inc. was founded in 1971 and is headquartered in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.71 > 1.0 |
| NWC/Revenue: 0.51% < 20% (prev -1.57%; Δ 2.08% < -1%) |
| CFO/TA 0.07 > 3% & CFO 2.25b > Net Income 1.79b |
| Net Debt (9.11b) to EBITDA (3.13b): 2.91 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (576.5m) vs 12m ago -0.43% < -2% |
| Gross Margin: 47.93% > 18% (prev 0.40%; Δ 4753 % > 0.5%) |
| Asset Turnover: 26.75% > 50% (prev 24.34%; Δ 2.41% > 0%) |
| Interest Coverage Ratio: 7.01 > 6 (EBITDA TTM 3.13b / Interest Expense TTM 356.0m) |
Altman Z'' 2.00
| A: 0.00 (Total Current Assets 8.00b - Total Current Liabilities 7.96b) / Total Assets 31.05b |
| B: 0.31 (Retained Earnings 9.59b / Total Assets 31.05b) |
| C: 0.08 (EBIT TTM 2.49b / Avg Total Assets 30.72b) |
| D: 0.42 (Book Value of Equity 7.82b / Total Liabilities 18.82b) |
| Altman-Z'' Score: 2.00 = BBB |
Beneish M -3.25
| DSRI: 0.83 (Receivables 943.0m/1.02b, Revenue 8.22b/7.40b) |
| GMI: 0.84 (GM 47.93% / 40.42%) |
| AQI: 0.99 (AQ_t 0.70 / AQ_t-1 0.71) |
| SGI: 1.11 (Revenue 8.22b / 7.40b) |
| TATA: -0.02 (NI 1.79b - CFO 2.25b) / TA 31.05b) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
What is the price of NDAQ shares?
As of February 26, 2026, the stock is trading at USD 83.99 with a total of 5,175,949 shares traded.
Over the past week, the price has changed by +2.26%, over one month by -15.07%, over three months by -5.49% and over the past year by +6.88%.
Over the past week, the price has changed by +2.26%, over one month by -15.07%, over three months by -5.49% and over the past year by +6.88%.
Is NDAQ a buy, sell or hold?
Nasdaq has received a consensus analysts rating of 3.95.
Therefore, it is recommended to buy NDAQ.
- StrongBuy: 6
- Buy: 7
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the NDAQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 107.7 | 28.3% |
| Analysts Target Price | 107.7 | 28.3% |
NDAQ Fundamental Data Overview February 21, 2026
P/E Trailing = 26.6046
P/E Forward = 20.6612
P/S = 5.6263
P/B = 3.7112
P/EG = 1.4443
Revenue TTM = 8.22b USD
EBIT TTM = 2.49b USD
EBITDA TTM = 3.13b USD
Long Term Debt = 8.57b USD (from longTermDebt, last quarter)
Short Term Debt = 431.0m USD (from shortTermDebt, last quarter)
Debt = 9.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.11b USD (from netDebt column, last quarter)
Enterprise Value = 55.57b USD (46.48b + Debt 9.93b - CCE 842.0m)
Interest Coverage Ratio = 7.01 (Ebit TTM 2.49b / Interest Expense TTM 356.0m)
EV/FCF = 27.94x (Enterprise Value 55.57b / FCF TTM 1.99b)
FCF Yield = 3.58% (FCF TTM 1.99b / Enterprise Value 55.57b)
FCF Margin = 24.20% (FCF TTM 1.99b / Revenue TTM 8.22b)
Net Margin = 21.77% (Net Income TTM 1.79b / Revenue TTM 8.22b)
Gross Margin = 47.93% ((Revenue TTM 8.22b - Cost of Revenue TTM 4.28b) / Revenue TTM)
Gross Margin QoQ = 66.92% (prev 44.43%)
Tobins Q-Ratio = 1.79 (Enterprise Value 55.57b / Total Assets 31.05b)
Interest Expense / Debt = 0.89% (Interest Expense 88.0m / Debt 9.93b)
Taxrate = 10.52% (61.0m / 580.0m)
NOPAT = 2.23b (EBIT 2.49b * (1 - 10.52%))
Current Ratio = 1.01 (Total Current Assets 8.00b / Total Current Liabilities 7.96b)
Debt / Equity = 0.81 (Debt 9.93b / totalStockholderEquity, last quarter 12.23b)
Debt / EBITDA = 2.91 (Net Debt 9.11b / EBITDA 3.13b)
Debt / FCF = 4.58 (Net Debt 9.11b / FCF TTM 1.99b)
Total Stockholder Equity = 11.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.82% (Net Income 1.79b / Total Assets 31.05b)
RoE = 15.03% (Net Income TTM 1.79b / Total Stockholder Equity 11.90b)
RoCE = 12.18% (EBIT 2.49b / Capital Employed (Equity 11.90b + L.T.Debt 8.57b))
RoIC = 10.60% (NOPAT 2.23b / Invested Capital 21.05b)
WACC = 7.34% (E(46.48b)/V(56.41b) * Re(8.74%) + D(9.93b)/V(56.41b) * Rd(0.89%) * (1-Tc(0.11)))
Discount Rate = 8.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.32%
[DCF] Terminal Value 81.93% ; FCFF base≈1.89b ; Y1≈2.10b ; Y5≈2.76b
[DCF] Fair Price = 80.24 (EV 54.73b - Net Debt 9.11b = Equity 45.61b / Shares 568.4m; r=7.34% [WACC]; 5y FCF grow 13.13% → 2.90% )
EPS Correlation: 82.34 | EPS CAGR: 10.51% | SUE: 2.30 | # QB: 3
Revenue Correlation: 87.87 | Revenue CAGR: 8.44% | SUE: 3.61 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.92 | Chg7d=+0.001 | Chg30d=+0.014 | Revisions Net=+6 | Analysts=13
EPS current Year (2026-12-31): EPS=3.90 | Chg7d=+0.008 | Chg30d=+0.044 | Revisions Net=+3 | Growth EPS=+12.0% | Growth Revenue=+8.5%
EPS next Year (2027-12-31): EPS=4.36 | Chg7d=-0.001 | Chg30d=+0.075 | Revisions Net=+2 | Growth EPS=+11.8% | Growth Revenue=+8.2%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 8.7% - Earnings Yield 3.8%)
[Growth] Growth Spread = +5.6% (Analyst 10.6% - Implied 5.0%)
P/E Forward = 20.6612
P/S = 5.6263
P/B = 3.7112
P/EG = 1.4443
Revenue TTM = 8.22b USD
EBIT TTM = 2.49b USD
EBITDA TTM = 3.13b USD
Long Term Debt = 8.57b USD (from longTermDebt, last quarter)
Short Term Debt = 431.0m USD (from shortTermDebt, last quarter)
Debt = 9.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.11b USD (from netDebt column, last quarter)
Enterprise Value = 55.57b USD (46.48b + Debt 9.93b - CCE 842.0m)
Interest Coverage Ratio = 7.01 (Ebit TTM 2.49b / Interest Expense TTM 356.0m)
EV/FCF = 27.94x (Enterprise Value 55.57b / FCF TTM 1.99b)
FCF Yield = 3.58% (FCF TTM 1.99b / Enterprise Value 55.57b)
FCF Margin = 24.20% (FCF TTM 1.99b / Revenue TTM 8.22b)
Net Margin = 21.77% (Net Income TTM 1.79b / Revenue TTM 8.22b)
Gross Margin = 47.93% ((Revenue TTM 8.22b - Cost of Revenue TTM 4.28b) / Revenue TTM)
Gross Margin QoQ = 66.92% (prev 44.43%)
Tobins Q-Ratio = 1.79 (Enterprise Value 55.57b / Total Assets 31.05b)
Interest Expense / Debt = 0.89% (Interest Expense 88.0m / Debt 9.93b)
Taxrate = 10.52% (61.0m / 580.0m)
NOPAT = 2.23b (EBIT 2.49b * (1 - 10.52%))
Current Ratio = 1.01 (Total Current Assets 8.00b / Total Current Liabilities 7.96b)
Debt / Equity = 0.81 (Debt 9.93b / totalStockholderEquity, last quarter 12.23b)
Debt / EBITDA = 2.91 (Net Debt 9.11b / EBITDA 3.13b)
Debt / FCF = 4.58 (Net Debt 9.11b / FCF TTM 1.99b)
Total Stockholder Equity = 11.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.82% (Net Income 1.79b / Total Assets 31.05b)
RoE = 15.03% (Net Income TTM 1.79b / Total Stockholder Equity 11.90b)
RoCE = 12.18% (EBIT 2.49b / Capital Employed (Equity 11.90b + L.T.Debt 8.57b))
RoIC = 10.60% (NOPAT 2.23b / Invested Capital 21.05b)
WACC = 7.34% (E(46.48b)/V(56.41b) * Re(8.74%) + D(9.93b)/V(56.41b) * Rd(0.89%) * (1-Tc(0.11)))
Discount Rate = 8.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.32%
[DCF] Terminal Value 81.93% ; FCFF base≈1.89b ; Y1≈2.10b ; Y5≈2.76b
[DCF] Fair Price = 80.24 (EV 54.73b - Net Debt 9.11b = Equity 45.61b / Shares 568.4m; r=7.34% [WACC]; 5y FCF grow 13.13% → 2.90% )
EPS Correlation: 82.34 | EPS CAGR: 10.51% | SUE: 2.30 | # QB: 3
Revenue Correlation: 87.87 | Revenue CAGR: 8.44% | SUE: 3.61 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.92 | Chg7d=+0.001 | Chg30d=+0.014 | Revisions Net=+6 | Analysts=13
EPS current Year (2026-12-31): EPS=3.90 | Chg7d=+0.008 | Chg30d=+0.044 | Revisions Net=+3 | Growth EPS=+12.0% | Growth Revenue=+8.5%
EPS next Year (2027-12-31): EPS=4.36 | Chg7d=-0.001 | Chg30d=+0.075 | Revisions Net=+2 | Growth EPS=+11.8% | Growth Revenue=+8.2%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.0% (Discount Rate 8.7% - Earnings Yield 3.8%)
[Growth] Growth Spread = +5.6% (Analyst 10.6% - Implied 5.0%)